PMC:7441788 / 18010-18682
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T108 | 533-536 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T109 | 567-590 | Body_part | denotes | upper respiratory tract | http://purl.org/sig/ont/fma/fma45661 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T8 | 567-590 | Body_part | denotes | upper respiratory tract | http://purl.obolibrary.org/obo/UBERON_0001557 |
| T9 | 573-590 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T181 | 8-9 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T229 | 26-31 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T230 | 203-212 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-sample-MedDRA
| Id | Subject | Object | Predicate | Lexical cue | meddra_id |
|---|---|---|---|---|---|
| T9 | 77-89 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | investigator | http://purl.bioontology.org/ontology/MEDDRA/10062026 |
| T10 | 603-625 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | bronchoalveolar lavage | http://purl.bioontology.org/ontology/MEDDRA/10049413 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T136 | 533-536 | Chemical | denotes | RNA | http://purl.obolibrary.org/obo/CHEBI_33697 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T135 | 0-198 | Sentence | denotes | Lack of a placebo control group; Design introduces the possibility of biased investigator determined assessment and unbalanced dosage adjustment; Randomization of sequential envelopes may be biased. |
| T136 | 199-382 | Sentence | denotes | The antiviral efficacy of HCQ was not assessed at an earlier stage; Most patients are mild to severe, and the effect of HCQ on disease progression or regression could not be provided. |
| T137 | 383-459 | Sentence | denotes | The trial terminated early due to the difficulty to recruit enough patients. |
| T138 | 460-672 | Sentence | denotes | Some secondary endpoints could not be analyzed by the cutoff date; Viral RNA specimens are mostly from the upper respiratory tract rather than bronchoalveolar lavage fluid, which may cause false negative results. |
LitCovid-sample-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T8 | 567-590 | Body_part | denotes | upper respiratory tract | http://purl.obolibrary.org/obo/UBERON_0001557 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 645 | 272-280 | Species | denotes | patients | Tax:9606 |
| 646 | 450-458 | Species | denotes | patients | Tax:9606 |
| 674 | 225-228 | Chemical | denotes | HCQ | MESH:D006886 |
| 675 | 319-322 | Chemical | denotes | HCQ | MESH:D006886 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T120 | 203-212 | http://purl.obolibrary.org/obo/IDO_0000559 | denotes | antiviral |
| T121 | 326-333 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T107 | 533-536 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T108 | 567-590 | Body_part | denotes | upper respiratory tract | http://purl.org/sig/ont/fma/fma45661 |
LitCovid-sample-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T60 | 649-654 | http://purl.obolibrary.org/obo/GO_0071878 | denotes | false |
| T61 | 649-654 | http://purl.obolibrary.org/obo/GO_0071877 | denotes | false |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 645 | 272-280 | Species | denotes | patients | Tax:9606 |
| 646 | 450-458 | Species | denotes | patients | Tax:9606 |
| 674 | 225-228 | Chemical | denotes | HCQ | MESH:D006886 |
| 675 | 319-322 | Chemical | denotes | HCQ | MESH:D006886 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T135 | 0-198 | Sentence | denotes | Lack of a placebo control group; Design introduces the possibility of biased investigator determined assessment and unbalanced dosage adjustment; Randomization of sequential envelopes may be biased. |
| T136 | 199-382 | Sentence | denotes | The antiviral efficacy of HCQ was not assessed at an earlier stage; Most patients are mild to severe, and the effect of HCQ on disease progression or regression could not be provided. |
| T137 | 383-459 | Sentence | denotes | The trial terminated early due to the difficulty to recruit enough patients. |
| T138 | 460-672 | Sentence | denotes | Some secondary endpoints could not be analyzed by the cutoff date; Viral RNA specimens are mostly from the upper respiratory tract rather than bronchoalveolar lavage fluid, which may cause false negative results. |